Multi-sectorial research is paramount for preventing and controlling emerging infectious diseases.

Adaptability Adaptabilité Approche multisectorielle Emerging infectious disease Maladies infectieuses émergentes Multi-sectorial approach Recherche Research Seminar Séminaire Transversality Transversalité

Journal

Revue d'epidemiologie et de sante publique
ISSN: 0398-7620
Titre abrégé: Rev Epidemiol Sante Publique
Pays: France
ID NLM: 7608039

Informations de publication

Date de publication:
Apr 2020
Historique:
received: 17 07 2019
accepted: 04 09 2019
pubmed: 22 12 2019
medline: 9 10 2020
entrez: 22 12 2019
Statut: ppublish

Résumé

The social, economic and political consequences of emerging infectious disease (EID) may escape the sphere in which they first arise. In recent years, many EIDs have revealed the close links between human, animal and plant health, highlighting the need for multi-scale, multisectorial EID management. Human beings play a dual role in EID because they can promote their development through numerous human-environment interfaces and expanding international trade. On the other hand, their ability to analyze, interpret and act on the determinants of EID allows them to access the expertise necessary to control these EIDs. This expertise must be constantly adapted to remain relevant as the EID evolves, particularly in its virulence or transmission channels. Flexibility should become an inherent part of the expertise-based decision-making process even if it means going backwards. A certain degree of transparency and feedback to citizens is necessary for the acceptability of political decisions basing on expertise. A key step in the management of EID is the appropriate management of the early signal of infectious emergence. This step combines multidisciplinary skills allowing access to the best pathway for containing EID by implementing early countermeasures adapted to the situation. New digital technologies could significantly improve this early detection phase. Finally, experts have a fundamental role to play because they are located at the interface between operational actors and decision-makers, which allows multidirectional feedback, ideally in real time, between professional actors and decision makers. To combat current and future EIDs, expertise should be based on a multi-sectorial approach, promotion of collegiality and continuously adaptation to the evolving nature of EIDs.

Identifiants

pubmed: 31862272
pii: S0398-7620(19)30520-6
doi: 10.1016/j.respe.2019.09.009
pmc: PMC7130708
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

133-136

Informations de copyright

Copyright © 2019 Elsevier Masson SAS. All rights reserved.

Références

Nat Commun. 2019 Jan 8;10(1):80
pubmed: 30622259
Nature. 2008 Feb 21;451(7181):990-3
pubmed: 18288193
Prev Vet Med. 2011 Sep 1;101(3-4):148-56
pubmed: 20832879
Science. 2019 May 10;364(6440):584-587
pubmed: 31073065
Ecohealth. 2018 Jun;15(2):241-243
pubmed: 30003354
Lancet. 2016 May 28;387(10034):2183-5
pubmed: 27145708
Nat Commun. 2019 Feb 22;10(1):898
pubmed: 30796206
PLoS Pathog. 2015 Aug 06;11(8):e1004992
pubmed: 26247831
Lancet. 2012 Dec 1;380(9857):1936-45
pubmed: 23200502
Philos Trans R Soc Lond B Biol Sci. 2017 Jul 19;372(1725):
pubmed: 28584179

Auteurs

P Le Turnier (P)

Service des maladies infectieuses et tropicales, Hôtel-Dieu, centre hospitalier universitaire de Nantes, Nantes, France; Centre d'investigation clinique unité d'investigation clinique 1413, institut national de la santé et de la recherche médicale, centre hospitalier universitaire de Nantes, Nantes, France. Electronic address: paul.leturnier@chu-nantes.fr.

C Leport (C)

IAME, UMR 1137, Inserm, université Paris Diderot, Paris, France; Unité de coordination du risque épidémique et biologique, Assistance publique-Hôpitaux de Paris, Paris, France.

P Martin (P)

Consultant near the international network of Pasteur Institutes, Paris, France.

C Jadand (C)

IAME, UMR 1137, Inserm, université Paris Diderot, Paris, France.

B Hoen (B)

Maladies infectieuses et tropicales, centre hospitalier universitaire de Nancy, Nancy, France.

J-F Guégan (JF)

UMR ASTRE, INRA, Cirad, université de Montpellier, et UMR MIVEGEC IRD, CNRS, université de Montpelier, Montpellier, France; Future Earth United Nations International Programme, OneHealth Global Research Programme, Paris, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH